Clinically significant drug interactions in younger and older human immunodeficiency virus-positive patients receiving antiretroviral therapy

Pharmacotherapy

Volumn 31, Issue 5, 2011, Pages 480-489

  Yiu, Pannyun ^a   Nguyen, Nancy N ^a,b   Holodniy, Mark ^a  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF THE PACIFIC   (United States)

Author keywords

Antiretroviral therapy; Drug interactions; Elderly; HIV; Human immunodeficiency virus

Indexed keywords

ANALGESIC AGENT; ANTACID AGENT; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIDIABETIC AGENT; ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ANTILIPEMIC AGENT; ANTIRETROVIRUS AGENT; ANTITHROMBOCYTIC AGENT; ATAZANAVIR; ATORVASTATIN; CORTICOSTEROID; DILTIAZEM; ENFUVIRTIDE; HORMONE; HUMAN IMMUNODEFICIENCY VIRUS FUSION INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; PSYCHOTROPIC AGENT; RANITIDINE; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TAMSULOSIN; TRAZODONE; UNINDEXED DRUG;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG CLASSIFICATION; DRUG CONTRAINDICATION; DRUG INDICATION; ERECTILE DYSFUNCTION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PATIENT CARE; PHARMACODYNAMICS; PRESCRIPTION; RETROSPECTIVE STUDY; VIRUS LOAD;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTI-RETROVIRAL AGENTS; CALIFORNIA; DRUG INTERACTIONS; ELECTRONIC HEALTH RECORDS; FEMALE; HIV SEROPOSITIVITY; HOSPITALS, VETERANS; HUMANS; MALE; MEDICATION ERRORS; MIDDLE AGED; OUTPATIENT CLINICS, HOSPITAL; REGISTRIES; RETROSPECTIVE STUDIES; VETERANS; YOUNG ADULT;

EID: 79955575754     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.31.5.480     Document Type: Article

References (11)

1. Joint United Nations Programme on HIV/AIDS. Report on the global AIDS epidemic 2008. Geneva, Switzerland: joint United Nations programme on HIV/AIDS (UNAIDS), 2008. Available from www.unaids.org/en/KnowledgeCentre/HIVData/ GlobalReport/2008/2008-Global-report.asp. Accessed April 21, 2010.
2. Centers for Disease Control and Prevention. Cases of HIV infection and AIDS in the United States and dependent areas, 2007. HIV/AIDS surveillance report 2007; vol 19. Available from www.cdc.gov/hiv/topics/surveillance/ resources/reports/2007report/default.htm. Accessed June 14, 2010.
3. Smith G. Opening statement of Senator Gordon H. Smith. In: Aging hearing: HIV over fifty, exploring the new threat: hearing before the U.S. Senate special subcommittee on aging, 109th Cong., 1st Sess., May 2005. Washington, DC: Senate special committee on aging, 2005. Available from bulk.resource.org/gpo. gov/hearings/109s/23758.pdf. Accessed August 2, 2009.
4. Miller CD, El-Kholi R, Faragon JJ, Lodise TP. Prevalence and risk factors for clinically significant drug interactions with antiretroviral therapy. Pharmacotherapy 2007;27:1379-86. (Pubitemid 47530444)
5. Shah S, McGowan J, Opulski B, Lieblein A, Saperstein A. Identification of drug interactions involving ART in New York City HIV specialty clinics. Presented as a poster at the 14th conference on retroviruses and opportunistic infections, Los Angeles, CA, February 25-8, 2007. Available from www.retroconference.org/2007/Abstracts/28775.htm. Accessed August 8, 2009.
6. de Maat MM, de Boer A, Koks CH, et al. Evaluation of clinical pharmacist interventions on drug interactions in outpatient pharmaceutical HIV-care. J Clin Pharm Ther 2004;29:121-30. (Pubitemid 38482476)
7. DeLorenze GN, Follansbee SF, Nguyen DP, et al. Medication error in the care of HIV/AIDS patients: electronic surveillance, confirmation, and adverse events. Med Care 2005;43:III63-8.
8. Hellinger FJ, Encinosa WE. Inappropriate drug combinations among privately insured patients with HIV disease. Med Care 2005;43:III53-62.
9. Walker J, Wynne H. Review: the frequency and severity of adverse drug reactions in elderly people. Age Ageing 1994;23: 255-9. (Pubitemid 24158298)
10. Department of Health and Human Services, Panel on Antiretroviral Guidelines for Adult and Adolescents. Guidelines for the use of antiretroviral agents in HIV1-infected adults and adolescents, December 2009. Available from www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. Accessed April 1, 2010.
11. KatendeKyenda NL, Lubbe MS, Serfontein JH, Truter I. Prevalence of possible drug-drug interactions between antiretroviral agents in different age groups in a section of the private health care sector setting in South Africa. J Clin Pharm Ther 2008;33:393-400.